Concepedia

Vilas Wagh

VW

16

Publications

642

Citations

15

H-Index

2007

Active since

Affiliations

University of Cologne(Current)

Massachusetts General Hospital

Merck & Co., Inc., Rahway, NJ, USA (United States)

Imperial College London

Harvard University

Vilas Wagh is an author at University of Cologne specializing in stem cell research, stem cells, and cell biology.

Top concepts

Publications per year

2007–2023

16

Publications

16

Identification of genomic biomarkers for anthracycline-induced cardiotoxicity in human iPSC-derived cardiomyocytes: an in vitro repeated exposure toxicity approach for safety assessment

Umesh Chaudhari, Harshal Nemade, Vilas Wagh et al. · Archives of Toxicology · 2015 · 105 citations · Full text

Identification of Thalidomide-Specific Transcriptomics and Proteomics Signatures during Differentiation of Human Embryonic Stem Cells

Kesavan Meganathan, Smita Jagtap, Vilas Wagh et al. · PLoS ONE · 2012 · 91 citations · Full text

, , +21

P276-00, a novel cyclin-dependent inhibitor induces G1-G2 arrest, shows antitumor activity on cisplatin-resistant cells and significant <i>in vivo</i> efficacy in tumor models

Kalpana Joshi, Maggie J. Rathos, P. Mahajan et al. · Molecular Cancer Therapeutics · 2007 · 74 citations

Effects of Cryopreservation on the Transcriptome of Human Embryonic Stem Cells After Thawing and Culturing

Vilas Wagh, Kesavan Meganathan, Smita Jagtap et al. · Stem Cell Reviews and Reports · 2011 · 54 citations

, , +8

A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas

Roberta L. Beauchamp, Marianne F. James, Patrick DeSouza et al. · Oncotarget · 2015 · 49 citations · Full text

Rows per page

1–5 of 16